Jamie L. Arnst - Publications

2010-2014 University of Nebraska Medical Center, Omaha, NE, United States 

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Arnst JL, Hein AL, Taylor MA, Palermo NY, Contreras JI, Sonawane YA, Wahl AO, Ouellette MM, Natarajan A, Yan Y. Discovery and characterization of small molecule Rac1 inhibitors. Oncotarget. PMID 28410221 DOI: 10.18632/Oncotarget.16656  0.32
2016 Rana S, Blowers EC, Tebbe C, Contreras JI, Radhakrishnan P, Kizhake S, Zhou T, Rajule RN, Arnst J, Munkarah AR, Rattan R, Natarajan A. Isatin derived spirocyclic analogs with α-methylene-γ-butyrolactone as anticancer agents: A structure activity rela-tionship study. Journal of Medicinal Chemistry. PMID 27077228 DOI: 10.1021/Acs.Jmedchem.6B00400  0.32
2013 Arnst JL, Davies CW, Raja SM, Das C, Natarajan A. High-throughput compatible fluorescence resonance energy transfer-based assay to identify small molecule inhibitors of AMSH deubiquitinase activity. Analytical Biochemistry. 440: 71-7. PMID 23747283 DOI: 10.1016/J.Ab.2013.05.017  0.32
2013 Radhakrishnan P, Bryant VC, Blowers EC, Rajule RN, Gautam N, Anwar MM, Mohr AM, Grandgenett PM, Bunt SK, Arnst JL, Lele SM, Alnouti Y, Hollingsworth MA, Natarajan A. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2025-35. PMID 23444213 DOI: 10.1158/1078-0432.Ccr-12-2909  0.32
Show low-probability matches.